Many studies have furthermore demonstrated CD74 expression in various non-hematological cancers including gastric, colon, lung, and renal epithelial cancers [31-34], and moreover has the elevated expression level in several cancers served as a marker for tumor progression and/or poor clinical outcome [35]. This evidence concerns the gene CD74 and hematopoietic and lymphoid cell neoplasm.